A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Clinical trial NCT05118789 · RECRUITING

Trial details

NCT number: NCT05118789
Sponsor: Nuvalent Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2022-01-04
Primary completion: 2027-12-31
Enrollment: 359

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.